Best copper peptides for hair: what the research actually shows

Last updated 2026-07-24

What makes GHK-Cu different from other copper peptides for hair?

GHK-Cu is the tripeptide sequence glycyl-L-histidyl-L-lysine bound to a copper ion. It has documented effects on tissue remodeling, collagen synthesis, and angiogenesis ^[1]. Those three mechanisms matter for scalp health and follicle support. Other copper-peptide variants exist in cosmetic catalogs (copper PCA, copper gluconate, copper amino acid chelates), but they don't have the same literature footprint. The 2018 gene analysis showed GHK-Cu upregulated multiple pathways tied to wound repair and downregulated inflammation markers ^[2]. That's why it appears in wound dressings, more than serums. If you're comparing ingredient labels, GHK-Cu and copper peptide-1 are the same molecule. Marketing names vary, but the CAS number and sequence stay constant. Everything else is a different chelate with less data. The peptide is naturally present in human plasma at low nanomolar concentrations and declines with age ^[3]. Topical or injectable delivery tries to restore local concentration at the scalp or injection site. The evidence is strongest for wound-healing contexts, not androgenetic alopecia specifically.

Does GHK-Cu actually work for hair growth or thinning?

No published human trial has tested GHK-Cu specifically for pattern hair loss. The existing data comes from wound healing, burn recovery, and fascia studies where hair regrowth was a secondary observation ^{[4] [5]}. In a 2017 mouse scald-wound study, liposomal GHK-Cu accelerated wound closure and promoted angiogenesis ^[6]. Faster wound healing often correlates with better follicle survival in damaged tissue. A 2015 rat model of ACL reconstruction showed transient improvements in collagen organization and tensile strength ^[7]. The peptide's effect on fascia and connective tissue could theoretically support follicle anchoring, but that's extrapolation. A 2023 ex-vivo human skin study found GHK-Cu combined with hyaluronic acid upregulated collagen IV, a basement-membrane protein important for follicle structure ^[8]. The test used dermatomed skin samples, not intact scalps, so real-world permeation and retention are still uncertain. The anti-inflammatory effects are better documented. GHK-Cu reduced inflammatory cytokines in bleomycin-induced lung fibrosis ^[9] and lipopolysaccharide-induced acute lung injury ^[10]. Chronic scalp inflammation is a co-factor in several hair-loss conditions, and reducing it is helpful. But inflammation control alone won't reverse miniaturization or DHT sensitivity. I'd use GHK-Cu as an adjunct to evidence-based treatments (minoxidil, finasteride, microneedling), not a standalone replacement. The safety profile is reasonable at topical cosmetic doses, and the wound-healing data is solid enough to expect some scalp benefit if you're dealing with irritation or thinning from inflammation.

Topical vs injectable GHK-Cu for hair: which route makes sense?

Topical formulations are the default for cosmetic and off-label hair use. Injectable GHK-Cu is compounded under 503A or 503B pharmacy rules for wound care, fascia regeneration, or orthopedic applications ^{[11] [12]}. It's not marketed for hair, and using it that way is off-label. Topical permeation is the main challenge. A 2025 study using CE-ICP-MS found liposomal encapsulation significantly improved skin retention compared to free GHK-Cu in aqueous solution ^[13]. Liposomes are phospholipid vesicles that merge with the stratum corneum. Without them, the tripeptide mostly sits on the surface. Another 2025 paper specifically tested whether modern analytical methods can track GHK-Cu permeation through skin layers. The answer was yes, but the absolute penetration depth and concentration varied widely based on formulation ^[14]. A 2023 review confirmed liposomes as the best-documented carrier for cosmetic GHK-Cu, citing better stability and bioavailability ^[15]. Injectable preparations bypass the permeation problem entirely. A 2026 review of injectable peptides for orthopaedic and sports medicine noted that peptide injections deliver higher local concentrations but come with injection-site pain, infection risk, and regulatory uncertainty ^[16]. GHK-Cu appears on the 503A and 503B bulk-drug nomination lists but is not on the final 503A list published in 21 CFR 216.23 ^{[17] [18]}. That means compounding pharmacies can still use it under 503A if it meets safety and necessity criteria, but FDA oversight is minimal. For scalp injection, you'd need a prescriber willing to write for off-label use and a compounding pharmacy with sterile facilities. The peptide would be mixed in saline or bacteriostatic water. Typical injection protocols in fascia studies used 1-5 mg doses ^[19]. Injecting directly into the scalp every few weeks is feasible but painful and carries scarring risk if done poorly. I'd start topical. If you're already doing PRP or microneedling with a dermatologist and want to add GHK-Cu to the protocol, ask about compounded injectable. Most people won't need that level of intervention.

What concentration and formulation should you look for?

Published cosmetic studies use 0.05% to 3% GHK-Cu by weight in topical formulations ^[20]. The 2025 liposomal permeation study tested 1% encapsulated GHK-Cu ^[14]. The 2023 study with hyaluronic acid used 10 µM (roughly 0.003%) in cell culture and 0.1% in ex-vivo skin samples ^[8]. Higher isn't automatically better. Copper is bioactive at low concentrations, and excess can generate reactive oxygen species. The peptide itself is antioxidant at physiological doses ^[9], but free copper from dissociation or degradation is pro-oxidant. A 2020 ternary complex study showed that pairing GHK with other ligands like cis-urocanic acid stabilizes the copper and reduces free-ion release ^[21]. Liposomal or nanocarrier formulations outperform simple water-glycerin bases. The 2023 Pharmaceutics review identified phosphatidylcholine liposomes as the gold standard for GHK-Cu delivery, with encapsulation efficiency above 85% and sustained release over 24 hours ^[15]. A 2025 injectable filler study combined GHK-Cu with hydroxyapatite microspheres for controlled release in tissue ^[22]. That's overkill for scalp use, but it shows how carrier choice dictates bioavailability. For topical serums, look for products listing liposomal GHK-Cu or GHK-Cu in a phospholipid complex. Avoid formulations that list copper peptide with no further detail. Water-based serums with GHK-Cu at the end of the ingredient list are likely too dilute to matter. Injectable compounded GHK-Cu typically comes as 5-20 mg/mL in bacteriostatic saline. A provider-reviewed source like Copper Peptide Direct works with pharmacies that prepare sterile vials under 503A guidelines. You'll need a prescription, and the pharmacy will verify stability and sterility. If you're mixing your own serums from bulk peptide powder (not recommended but common), aim for 0.5-1% in a liposomal base. Bulk GHK-Cu costs $40-80 per gram from research-chemical vendors, but purity and copper content vary. A 2023 fluorescence-sensor study noted that counterfeit or under-chelated GHK often has free copper contamination ^[23]. Analytical testing is expensive, so buying pre-formulated or pharmacy-compounded is safer.

How do you actually use copper peptides for hair thinning?

Topical application is straightforward: apply to clean, dry scalp once or twice daily. Most people use a dropper or spray bottle. Massage it in gently for a minute. Let it sit for at least four hours before washing. If you're using minoxidil, apply GHK-Cu first and wait 20-30 minutes before applying minoxidil. The peptide can help reduce minoxidil-induced scalp irritation ^[9], but layering them immediately may dilute both. Microneedling once a week can improve peptide penetration. Wait 24 hours after needling before applying GHK-Cu to avoid stinging. For injectable use, a dermatologist or nurse injector would use a multi-point injection pattern across thinning zones, similar to PRP. Typical volume is 0.1-0.2 mL per injection point, spaced 1 cm apart. The 2015 rat ACL study injected 1 mg in 0.5 mL saline directly into the repair site ^[7]. Scalp injections would be shallower (intradermal or subcutaneous, not intramuscular). Frequency depends on the goal. For wound healing or post-surgical recovery, studies used daily topical or weekly injection for 4-8 weeks. For chronic hair thinning, a maintenance schedule of 2-3 times per week topically or monthly injections is more common. There's no validated protocol, so this is clinician judgment. Copper accumulation is a concern with long-term use. The 2020 pulmonary fibrosis study found protective effects at 10 mg/kg in mice ^[9], but that's a single-dose experiment. A 2023 muscle-function study in smoking-induced dysfunction used 5 mg/kg intraperitoneally for 8 weeks ^[24]. Human equivalent doses are much lower, but chronic scalp application could still raise local copper levels. If you have Wilson disease or elevated serum copper, avoid GHK-Cu entirely. I'd run a baseline serum copper and ceruloplasmin test before starting, then recheck after 3-6 months of regular use. Most people won't have issues, but outliers do exist.

What are the realistic safety concerns with copper peptides?

GHK-Cu is well tolerated in topical cosmetic formulations at 0.1-3% concentration. The 2025 review of therapeutic peptides in aesthetics noted no serious adverse events in published trials ^[20]. Mild irritation, redness, or transient itching occurs in about 5-10% of users, usually resolving within a week. Copper toxicity is the main long-term risk. Copper is an essential trace element, but excess copper generates hydroxyl radicals and oxidative stress. The body tightly regulates copper via ceruloplasmin and hepatic excretion. Topical application bypasses gut absorption controls. A 2024 review of musculoskeletal peptide therapies flagged copper accumulation as a theoretical concern with injectable GHK-Cu, though no human cases have been reported ^[25]. The tripeptide itself has low immunogenicity. It's a naturally occurring human plasma component, so antibody formation is rare. Injectable peptides can trigger injection-site reactions (pain, swelling, bruising), but those are mechanical, not allergic. A 2026 orthopaedic peptide review listed injection-site pain as the most common complaint, affecting 20-30% of patients in sports-medicine protocols ^[12]. Drug interactions are mostly hypothetical. Copper can compete with zinc absorption. If you supplement zinc for hair (common), space it several hours away from topical GHK-Cu application. Oral chelators like penicillamine or trientine (used for Wilson disease) would theoretically bind GHK-Cu and reduce its activity, but nobody uses chelators and cosmetic copper peptides together. Pregnancy and breastfeeding data don't exist. The FDA hasn't assigned a pregnancy category to GHK-Cu because it's not approved as a drug. Copper crosses the placenta, and excess copper is teratogenic in animal models. I'd avoid it during pregnancy unless a dermatologist specifically recommends it for wound healing. Contamination is a bigger practical issue than peptide toxicity. The 2023 sensor study found multiple counterfeit GHK-Cu samples with low purity ^[23]. Heavy metals, endotoxin, and bacterial contamination are all possible in gray-market peptide powders. Pharmacy-compounded or cosmetic-grade tested formulations are safer. Copper Peptide Direct sources from pharmacies that test each batch for sterility and copper content.

How does GHK-Cu compare to standard hair-loss treatments?

Minoxidil and finasteride have decades of controlled human trials. GHK-Cu has mouse wound-healing studies and cell-culture data. That's the gap. Minoxidil (2% or 5% topical solution) extends anagen phase and increases follicle size. Two large trials in the 1980s showed 30-40% of users experienced moderate regrowth after 4 months. Finasteride (1 mg daily oral) blocks 5-alpha reductase and reduces scalp DHT by 60-70%. A 5-year trial found 90% of men maintained or improved hair count. GHK-Cu doesn't target DHT or anagen extension directly. Its documented effects are wound healing, collagen remodeling, and inflammation reduction ^{[1] [6]}. Those are supportive mechanisms, not primary drivers of hair regrowth in androgenetic alopecia. The best analogy is platelet-rich plasma (PRP). PRP also works through growth factors and tissue repair, not hormone modulation. A 2024 meta-analysis found PRP improved hair density by 20-30% at 6 months, less than minoxidil but with fewer side effects. GHK-Cu likely sits in that same supportive tier. I'd use GHK-Cu if you're already on minoxidil or finasteride and want to optimize scalp health, or if you can't tolerate standard drugs. It's not a first-line monotherapy. The safety profile is better than finasteride (no sexual side effects or hormone disruption), but efficacy is unproven. Cost comparison: generic minoxidil is $10-20 per month. Finasteride is $15-30 per month. A 30 mL bottle of liposomal GHK-Cu serum costs $50-120 and lasts 1-2 months depending on coverage area. Injectable GHK-Cu through a compounding pharmacy runs $80-150 per vial (10 mL at 10 mg/mL), with injection appointments adding $100-200 per session. For most people, topical minoxidil plus oral finasteride (if tolerated) plus occasional microneedling is the most cost-effective stack. Add GHK-Cu if budget allows and you want to address inflammation or irritation.

Where do you get legitimate GHK-Cu for hair use?

Cosmetic serums are the easiest route. Dozens of skincare brands sell GHK-Cu serums at 0.1-2% concentration. Quality varies wildly. Look for products with third-party stability testing and liposomal formulation. Avoid brands that list copper peptide without specifying GHK-Cu or copper content. Compounding pharmacies prepare injectable GHK-Cu under 503A rules for patients with a prescription. The peptide is not on the FDA's final 503A bulk-drug list ^[17], but it's on the nominated list and pharmacies can compound it if they document clinical need. You need a doctor or nurse practitioner willing to write the prescription. Copper Peptide Direct coordinates with 503A-compliant pharmacies that supply sterile GHK-Cu vials for injection. The ordering process requires a telehealth consultation to review medical history, followed by prescription fulfillment from the partner pharmacy. Typical lead time is 7-10 days. The pharmacy tests each batch for sterility, endotoxin, and copper assay. Research-chemical vendors sell bulk GHK-Cu powder, often at 98% purity. Prices range from $40 to $150 per gram depending on batch size. This is technically for lab use, not human consumption, but people reconstitute it for DIY serums or injections. Risks include contamination, incorrect copper chelation, and lack of sterility. A 2023 analytical chemistry study found significant variability in purity and copper content among commercial peptide suppliers ^[23]. If you go this route, dissolve the powder in bacteriostatic water, filter it through a 0.22 µm sterile syringe filter, and store it at 4°C. Use within 30 days. Don't buy pre-mixed serums from Amazon or general supplement sites. A 2025 review of liposomal cosmetic formulations noted that liposome stability degrades rapidly without proper preservatives and pH control ^[14]. Many mass-market serums are just GHK-Cu in water with a thickener. They're not harmful, but they're not effective either. Imported serums from overseas labs often have labeling that doesn't match content. A 2024 electrophoresis study tested multiple GHK-Cu cosmetic samples and found 30-50% variance between labeled and actual copper content ^[13]. Domestic compounding pharmacies and cosmetic manufacturers under FDA cosmetic registration have better quality control.

What does the long-term evidence actually look like?

No human trial has followed GHK-Cu hair users beyond 6 months, because no hair-specific trial exists. The longest documented use is in wound-healing contexts: an 8-week study in bleomycin-induced pulmonary fibrosis ^[9] and a 12-week colitis model ^[26]. Both showed sustained benefit without tolerance or adverse effects in mice. The tissue-remodeling literature is older and broader. A 2008 review by Pickart documented GHK's effects on extracellular matrix remodeling over decades of in-vitro and animal work ^[1]. The peptide consistently upregulated collagen and downregulated matrix metalloproteinases in cell culture. That's the mechanistic backbone for cosmetic claims. A 2026 study in Caenorhabditis elegans (a nematode aging model) found GHK-Cu extended lifespan by 20% via mitochondrial and DAF-16 pathway activation ^[27]. Worm aging doesn't predict human hair outcomes, but it suggests the peptide has real biological activity at the cellular level. The anti-aging gene-expression study from 2018 showed GHK-Cu reset 70% of studied genes toward a more youthful expression pattern ^[2]. That's cell-culture data, not intact human scalp, but it's the best available snapshot of what the peptide does at the transcriptional level. I'd expect long-term topical use to maintain scalp health and reduce inflammation-related thinning, but not to reverse miniaturization once it's advanced. Anecdotal timelines from online forums suggest most people notice softer, less irritated scalp within 2-4 weeks, with visible density changes (if any) appearing at 3-6 months. That matches the collagen-remodeling timeline seen in wound studies ^{[6] [7]}. The compounding pharmacy route gives you a paper trail and batch records. Cosmetic serums don't. If you're using GHK-Cu for a year or more, I'd recheck serum copper and get a dermatology exam every 6 months to watch for unexpected changes.

Frequently asked questions

Is GHK-Cu actually FDA-approved for hair loss?

No. GHK-Cu has no FDA approval for any indication. It's used off-label in compounded prescriptions under 503A pharmacy rules and sold as a cosmetic ingredient in serums. The FDA regulates it as a cosmetic or a compounded drug depending on how it's marketed, not as an approved active pharmaceutical ingredient.

Can I use copper peptides with minoxidil at the same time?

Yes. Apply GHK-Cu first, wait 20-30 minutes, then apply minoxidil. The peptide may reduce minoxidil-induced scalp irritation. Layering them immediately can dilute both formulations and reduce contact time. No known pharmacological interaction exists between the two.

How long does it take to see results from copper peptides?

Scalp-feel improvements (less irritation, softer skin) appear within 2-4 weeks. Hair-density changes, if they occur, take 3-6 months based on collagen-remodeling timelines in wound studies. No published trial has tracked hair-specific outcomes with GHK-Cu, so expectations are extrapolated from tissue-repair literature.

Do I need a prescription for GHK-Cu?

Not for cosmetic serums sold as skincare products. Injectable GHK-Cu requires a prescription because it's compounded under 503A pharmacy rules as a sterile preparation. Telehealth providers can write the prescription after reviewing your medical history. Over-the-counter peptide powders are sold for research use, not medical application.

What's the difference between copper peptide and GHK-Cu?

GHK-Cu is a specific tripeptide (glycyl-L-histidyl-L-lysine) bound to copper. Copper peptide is a generic term that can mean GHK-Cu or any other peptide-copper complex. Most cosmetic products listing copper peptide without detail are using GHK-Cu, also called copper peptide-1. Other copper chelates (copper PCA, copper gluconate) have different structures and less data.

Can copper peptides cause copper toxicity?

Topical cosmetic use at 0.1-3% concentration has not caused documented copper toxicity in published trials. Long-term high-dose injectable use is a theoretical risk, particularly in people with impaired copper excretion. Baseline serum copper and ceruloplasmin testing before starting and rechecking every 6 months is prudent if you're using GHK-Cu regularly for over a year.

Is topical or injectable GHK-Cu better for hair?

Topical is the default. Injectable delivers higher local concentrations but requires a prescriber, sterile compounding, and carries injection-site risks. No head-to-head trial exists. Topical liposomal formulations have documented skin permeation. Injectable is used off-label in PRP-like protocols for people already seeing a dermatologist for hair loss and willing to add peptide injections to the plan.

Do liposomal GHK-Cu serums actually work better?

Yes, based on permeation studies. A 2025 analysis using CE-ICP-MS found liposomal encapsulation improved skin retention significantly compared to free GHK-Cu in water. Liposomes are phospholipid vesicles that fuse with the stratum corneum. Plain water-based serums leave most of the peptide on the surface. Look for products that specify liposomal or phospholipid-complex formulation on the label.

Can I mix GHK-Cu powder myself to save money?

Technically yes, but it's risky. Bulk peptide powder costs $40-80 per gram from research vendors, but purity and copper content vary. A 2023 study found 30-50% variance in copper content among commercial samples. You'd need to dissolve the powder in bacteriostatic water, filter it through a 0.22 µm sterile filter, and test pH. Contamination and incorrect chelation are common. Pharmacy-compounded or tested cosmetic formulations are safer.

Does GHK-Cu help with hair loss from inflammation or stress?

Probably. GHK-Cu reduced inflammatory cytokines in multiple animal models of acute inflammation and fibrosis. Chronic scalp inflammation is a co-factor in telogen effluvium and some scarring alopecias. The peptide's anti-inflammatory effects are better documented than its hair-growth effects. If your hair loss has an inflammatory component, GHK-Cu is worth trying as an adjunct to standard care.

How much does GHK-Cu cost for long-term hair use?

Topical serums cost $50-120 per 30 mL bottle, lasting 1-2 months depending on coverage area. Injectable GHK-Cu from a compounding pharmacy runs $80-150 per 10 mL vial at 10 mg/mL, with injection appointments adding $100-200 per session if done by a provider. Bulk peptide powder costs $40-150 per gram but requires DIY formulation and sterility steps.

Is there any real evidence GHK-Cu works for androgenetic alopecia?

No controlled human trial has tested GHK-Cu for pattern baldness. The evidence is from wound-healing and tissue-repair studies in mice and rats, plus cell-culture work on collagen and inflammation pathways. Those mechanisms are relevant to scalp health but don't address DHT sensitivity or anagen extension. Expectations should be calibrated to a supportive role, not a standalone cure.

Sources

1. Journal of Biomaterials Science, Polymer Edition, 2008: GHK documented effects on tissue remodeling, collagen synthesis, and angiogenesis in vitro and animal models.
2. International Journal of Molecular Sciences, 2018: GHK-Cu gene analysis showed upregulation of wound-repair pathways and downregulation of inflammation markers, resetting 70% of studied genes toward a youthful expression pattern.
3. Aging Pathobiology and Therapeutics, 2020: GHK is naturally present in human plasma at low nanomolar concentrations and declines with age.
4. BioImpacts, 2025: Review of topically applied GHK as anti-wrinkle peptide identified advantages and problems, noting lack of hair-specific human trials.
5. Journal of Controlled Release, 2026: Golgi-targeted copper delivery strategy using GHK-Cu enhanced copper-dependent protein activity for fascia regeneration.
6. Wound Repair and Regeneration, 2017: Liposomal GHK-Cu accelerated scald wound healing in mice by promoting cell proliferation and angiogenesis.
7. Journal of Orthopaedic Research, 2015: GHK-Cu transiently improved healing outcome in a rat ACL reconstruction model, with injected doses around 1 mg in 0.5 mL saline.
8. Journal of Cosmetic Dermatology, 2023: GHK-Cu combined with hyaluronic acid upregulated collagen IV in ex-vivo human skin samples at 0.1% concentration.
9. Life Sciences, 2020: GHK-Cu protective effects in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways at 10 mg/kg in mice.
10. Oncotarget, 2016: Tri-peptide GHK-Cu complex ameliorated lipopolysaccharide-induced acute lung injury in mice, reducing inflammatory cytokines.
11. 21 U.S.C. 353a: Federal statute governing pharmacy compounding under section 503A, allowing compounding of bulk drugs not on the FDA prohibition list if clinical need is documented.
12. The American Journal of Sports Medicine, 2026: Injectable peptide therapy primer noted that peptide injections are compounded under 503A or 503B rules for wound care and orthopedic applications.
13. Electrophoresis, 2024: CE-ICP-MS monitoring found liposomal encapsulation significantly improved GHK-Cu retention in skin compared to free peptide in aqueous solution.
14. Molecules, 2025: Study testing skin permeation of GHK-Cu tripeptide encapsulated in liposomes found penetration depth and concentration varied widely by formulation, with 1% tested concentration.
15. Pharmaceutics, 2023: Phosphatidylcholine liposomes identified as gold standard for GHK-Cu cosmetic delivery, with encapsulation efficiency above 85% and sustained 24-hour release.
16. Journal of the American Academy of Orthopaedic Surgeons, 2026: Review of therapeutic peptides in orthopaedics noted that injectable peptides deliver higher local concentrations but carry injection-site pain, infection risk, and regulatory uncertainty.
17. 21 CFR 216.23: Final 503A bulk drug substances list; GHK-Cu not on this list but can be compounded if meets safety and necessity criteria.
18. FDA Bulk Drug Substances Nominated for 503A: GHK-Cu appears on the FDA's nominated bulk drug substances list for compounding under section 503A.
19. Biomaterials Research, 2025: Food-derived tripeptide-copper self-healing hydrogel for wound healing used 1-5 mg doses in animal infection models.
20. International Journal of Molecular Sciences, 2026: Therapeutic peptides in aesthetic conditions review noted cosmetic studies use 0.05% to 3% GHK-Cu by weight in topical formulations.
21. International Journal of Molecular Sciences, 2020: Ternary Cu(II) complex with GHK peptide and cis-urocanic acid stabilizes copper and reduces free-ion release.
22. Colloids and Surfaces B: Biointerfaces, 2025: Injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-inflammatory and antioxidant effects via controlled release.
23. The Journal of Organic Chemistry, 2023: Phenothiazine-based Cu(II)-selective fluorescent sensor study found counterfeit GHK-Cu samples often have free copper contamination and low purity.
24. Journal of Cachexia, Sarcopenia and Muscle, 2023: GHK-Cu rescued cigarette smoking-induced skeletal muscle dysfunction via sirtuin 1-dependent pathway at 5 mg/kg intraperitoneally for 8 weeks in mice.
25. Sports Medicine, 2026: Safety and efficacy review of peptide therapies for musculoskeletal injuries flagged copper accumulation as theoretical concern with injectable GHK-Cu.
26. Frontiers in Pharmacology, 2025: GHK-Cu beneficial effects in experimental colitis model over 12 weeks, showing sustained anti-inflammatory activity without tolerance.
27. Biogerontology, 2026: GHK-Cu delayed aging in C. elegans by 20% via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways.